Difficulty: Medium
Average Score: 75%
Practice
A 54-year-old woman with severe hypercholesterolemia is to be treated with a combination of niacin and atorvastatin. With this drug combination, it is important that the patient be monitored closely for signs of
Correct answer
D
Rationale
In this scenario, the correct answer is D) Myopathy. When a patient is prescribed a combination of niacin and atorvastatin to manage hypercholesterolemia, they are at an increased risk of developing myopathy, which is a known adverse effect of statin medications like atorvastatin. Myopathy presents as muscle pain, weakness, or tenderness, and can progress to severe complications like rhabdomyolysis.
Option A) Agranulocytosis is not typically associated with niacin or atorvastatin therapy. Agranulocytosis is a condition characterized by a dangerously low white blood cell count.
Option B) Gallstones are not a common side effect of niacin or atorvastatin therapy. Gallstones are more commonly associated with rapid weight loss or high cholesterol levels.
Option C) Lactic acidosis is a rare but serious side effect of some medications like metformin, but it is not typically associated with niacin or atorvastatin.
Educationally, understanding the potential side effects of cardiovascular medications is crucial for nurses and healthcare providers to ensure patient safety and optimal outcomes. Monitoring for signs and symptoms of myopathy in patients on niacin and atorvastatin can help in early detection and management of this adverse effect, preventing serious complications.
Option A) Agranulocytosis is not typically associated with niacin or atorvastatin therapy. Agranulocytosis is a condition characterized by a dangerously low white blood cell count.
Option B) Gallstones are not a common side effect of niacin or atorvastatin therapy. Gallstones are more commonly associated with rapid weight loss or high cholesterol levels.
Option C) Lactic acidosis is a rare but serious side effect of some medications like metformin, but it is not typically associated with niacin or atorvastatin.
Educationally, understanding the potential side effects of cardiovascular medications is crucial for nurses and healthcare providers to ensure patient safety and optimal outcomes. Monitoring for signs and symptoms of myopathy in patients on niacin and atorvastatin can help in early detection and management of this adverse effect, preventing serious complications.